PhytoIntelligence 1.8 Finalized Evidence-Based Research Proposal Project D021.1: Multi-Pathway Network Pharmacology for GBM
This finalized proposal presents the biochemical rationale for the D021.1 formulation. Each component is selected based on its Cd score and supported by contemporary scientific literature (2021–2025). The protocol utilizes Borneol-mediated BBB opening and Berberine-mediated efflux inhibition to ensure that the primary flavonol matrix (Quercetin/Cannflavins) reaches therapeutic concentrations in the CNS.
Authors
- Marie Seshat Landry
Institutions
- International Society for Optics and Photonics (US)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-12-26
- DOI
- https://doi.org/10.5281/zenodo.18062531
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 0.00